Impact of pgl-i seropositivity on the protective effect of bcg vaccination among leprosy contacts: A cohort study

PLoS Neglected Tropical Diseases

Volumn 6, Issue 6, 2012, Pages

  Düppre, Nádia C ^a   Camacho, Luiz Antonio B ^a   Sales, Anna M ^a   Illarramendi, Ximena ^a   Nery, José Augusto C ^a   Sampaio, Elizabeth P ^a   Sarno, Euzenir N ^a   Bührer Sékula, Samira ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; IMMUNOGLOBULIN M; PHENOLIC GLYCOLIPID I; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; GLYCOLIPID; PHENOLIC GLYCOLIPID I, MYCOBACTERIUM LEPRAE;

ADOLESCENT; ADULT; AGE; ARTICLE; BCG VACCINATION; CHEMOPROPHYLAXIS; CHILD; COHORT ANALYSIS; CONTACT EXAMINATION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENDER; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; LEPROSY; MALE; NEWBORN; RISK; SERODIAGNOSIS; AGED; BLOOD; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM LEPRAE; PATHOGENICITY; PRESCHOOL CHILD; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; INFANT; LEPROSY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; RISK ASSESSMENT; YOUNG ADULT;

EID: 84863669387     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001711     Document Type: Article

References (37)

1. World Health Organization (2011) Leprosy elimination-New case detection. Available:http://www.who.int/lep/situation/new_cases/en/index.html. Accessed 19 October 2011.
2. Secretaria de Vigilância em Saúde-SVS Ministério da Saúde (n.d.) Situação Epidemiológica Hanseníase Brasil-2011. Available:http://portalsaude.saude.gov.br/portalsaude/arquivos/pdf/2012/Jan/26/hanseniase_2011_final.pdf. Accessed 3 February 2012.
3. Ministério da Saúde, Brasil. Percentual de grau de incapacidade 1 e 2 entre os casos novos de hanseníase Brasil, 2001 a 2009 (2010) http://portal.saude.gov.br/portal/arquivos/pdf/graf13_perc_incapacidade_1_2_br_2001_2009.pdf.
4. Ferreira J, Mengue SS, Wagner MB, Duncan BB, (2000) Estimating hidden prevalence in Hansen's disease through diagnosis delay and grade of disability at time of diagnosis. Int J Lepr Other Mycobact Dis 68: 464-473.
5. Visschedijk J, van de Broek J, Eggens H, Lever P, van Beers S, et al. (2000) Mycobacterium leprae-millennium resistant! Leprosy control on the threshold of a new era. Trop Med Int Health 5: 388-399.
6. van Beers SM, de Wit MY, Klatser PR, (1996) The epidemiology of Mycobacterium leprae: recent insight. FEMS Microbiol Lett 136: 221-230.
7. ILA Technical Forum (2012) Report of the International Leprosy Association Technical Forum, Paris 25-28 February 2002. Available:http://www.ilep.org.uk/fileadmin/uploads/Documents/techforum.pdf.
8. van Beers SM, Izumi S, Madjid B, Maeda Y, Day R, et al. (1994) An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr Other Mycobact Dis 62: 1-9.
9. Bakker MI, Hatta M, Kwenang A, Faber WR, van Beers SM, et al. (2004) Population survey to determine risk factors for Mycobacterium leprae transmission and infection. Int J Epidemiol 33: 1329-1336.
10. Cho SN, Kim SH, Cellona RV, Chan GP, Fajardo TT, et al. (1992) Prevalence of IgM antibodies to phenolic glycolipid I among household contacts and controls in Korea and the Philippines. Lepr Rev 63: 12-20.
11. Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, et al. (1991) IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy. Int J Lepr Other Mycobact Dis 59: 405-415.
12. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, et al. (2003) Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 41: 1991-1995.
13. Douglas JT, Cellona RV, Fajardo TT Jr, Abalos RM, Balagon MVF, et al. (2004) Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clin Diagn Lab Immunol 11: 897-900.
14. Groenen G, Pattyn SR, Ghys P, Tshilumba K, Kuykens L, et al. (1990) A longitudinal study of the incidence of leprosy in a hyperendemic area in Zaire, with special reference to PGL-antibody results. The Yalisombo Study Group. Int J Lepr Other Mycobact Dis 58: 641-650.
15. Bagshawe AF, Garsia RJ, Baumgart K, Astbury L, (1990) IgM serum antibodies to phenolic glycolipid-I and clinical leprosy: two years' observation in a community with hyperendemic leprosy. Int J Lepr Other Mycobact Dis 58: 25-30.
16. Chanteau S, Glaziou P, Plichart C, Luquiaud P, Plichart R, et al. (1993) Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Int J Lepr Other Mycobact Dis 61: 533-541.
17. Ministério da Saúde Secretaria de Vigilância em Saúde http://bvsms.saude.gov.br/bvs/saudelegis/svs/2009/poc0125_26_03_2009.html (n.d.) Portaria Conjunta n° 125, de 26 de Março de 2009.
18. Bagshawe A, Scott GC, Russell DA, Wigley SC, Merianos A, (1989) BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79. Bull World Health Organ 67: 389-399.
19. Düppre NC, Camacho LAB, da Cunha SS, Struchiner CJ, Sales AM, et al. (2008) Effectiveness of BCG vaccination among leprosy contacts: a cohort study. Trans R Soc Trop Med Hyg 102: 631-638.
20. Ridley DS, Jopling WH, et al. (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255-273.
21. Diário Oficial da União, Brasília (1991) Ministério da Saúde, 1991. Portaria n° 1.401, de 14 de agosto de 1991. Seção 1.
22. Bührer SS, Smits HL, Gussenhoven GC, van Ingen CW, Klatser PR, (1998) A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae. Am J Trop Med Hyg 58: 133-136.
23. Calado KLS, Vieira AG, Durães s, Bührer Sékula S, Oliveira MLW, (2005) Seropositivity with anti-PGL-I of household and neighbours contacts of leprosy patients in an urban area. Anais Brasileiros de Dermatologia 80 (Supl 3): S301-6.
24. Krishnamurthy P, Rao PS, Reddy BN, Subramanian M, Dhandayudapani S, (1991) Seroepidemiological study of leprosy in a highly endemic population of south India based on an ELISA using synthetic PGL-I. Int J Lepr Other Mycobact Dis 59: 426-431.
25. Maddison SE, Stewart CC, Farshy CE, Reimer CB, (1975) The relationship of race, sex, and age to concentrations of serum immunoglobulins expressed in international units in healthy adults in the USA. Bull World Health Organ 52: 179-185.
26. Baumgart KW, Britton WJ, Mullins RJ, Basten A, Barnetson RS, et al. (1993) Subclinical infection with Mycobacterium leprae-a problem for leprosy control strategies. Trans R Soc Trop Med Hyg 87: 412-415.
27. Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, et al. (2002) BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 359: 1393-1401.
28. Lima MC, Pereira GM, Rumjanek FD, Gomes HM, Duppre N, et al. (2000) Immunological cytokine correlates of protective immunity and pathogenesis in leprosy. Scand J Immunol 51: 419-428.
29. Sarno EN, Espinosa M, Sampaio EP, Vieira LM, Figueiredo AA, et al. (1988) Immunological responsiveness to M. leprae and BCG antigens in 98 leprosy patients and their household contacts. Braz J Med Biol Res 21: 461-470.
30. Sampaio EP, Moreira AL, Kaplan G, Alvim MF, Duppre NC, et al. (1991) Mycobacterium leprae-induced interferon-gamma production by household contacts of leprosy patients: association with the development of active disease. J Infect Dis 164: 990-993.
31. de Matos HJ, Duppre NC, Alvim MF, MachadoVieira LM, Sarno EN, et al. (1999) [Leprosy epidemiology in a cohort of household contacts in Rio de Janeiro (1987-1991)]. Cad Saude Publica 15: 533-542.
32. Vijayakumaran P, Jesudasan K, Mozhi NM, Samuel JD, (1998) Does MDT arrest transmission of leprosy to household contacts? Int J Lepr Other Mycobact Dis 66: 125-130.
33. Buschman e, Skamene e, Schurr E, (2002) Genetics of Human Susceptibility to Infectious Diseases: Progress and Prospects. The Genetic Basis of Common Diseases. Oxford University Press.
34. Dayal R, (1991) Early detection of leprosy in children. J Trop Pediatr 37: 310-312.
35. Sehgal VN, Chaudhry AK, (1993) Leprosy in children: a prospective study. Int J Dermatol 32: 194-197.
36. Lombardi C, (1984) Epidemiological aspects of mortality among patients with Hansen's disease in the State of São Paulo, Brazil (1931-1980). Rev Saude Publica 18: 71-107.
37. Fine PE, Sterne JA, Pönnighaus JM, Bliss L, Saui J, et al. (1997) Household and dwelling contact as risk factors for leprosy in northern Malawi. Am J Epidemiol 146: 91-102.